Date Published: November 29, 2016
Publisher: Public Library of Science
Author(s): Jacqueline Deen
Abstract: In a Perspective, Jacqueline Deeen discusses challenges in balancing the individual and population risks and benefits for CYD-TDV (Dengvaxia), the first available dengue vaccine.
Partial Text:
Source:
http://doi.org/10.1371/journal.pmed.1002182